Cutaneous leucocytoclastic vasculitis associated with omeprazole

32Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Omeprazole is a potent proton pump inhibitor and usually is well tolerated. Adverse effects of this drug have been reported in up to 5% of patients, most of which are trivial and disappear rapidly on discontinuation of the drug. Skin adverse reactions attributed to omeprazole are uncommon and include rashes, urticaria, angio-oedema, acute disseminated epidermal necrolysis, lichen spinulosus, and contact dermatitis. Cutaneous leucocytoclastic vasculitis (CLV) has not been previously reported in association with omeprazole. The development of CLV in an elderly patient four weeks after starting treatment with omeprazole is described.

Cite

CITATION STYLE

APA

Odeh, M., Lurie, M., & Oliven, A. (2002). Cutaneous leucocytoclastic vasculitis associated with omeprazole. Postgraduate Medical Journal, 78(916), 114–115. https://doi.org/10.1136/pmj.78.916.114

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free